Penthrox Inhaler Inhalation
Methoxyflurane
999mg/g
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
| Pack size | 10 Cobmipacks (3ml Glass Vial + Inhaler Device) |
|---|---|
| Dispensing mode | HOSPITAL ONLY |
| Source | AUSTRALIA |
| Agent | PHARMA SOLUTION DRUG STORE |
| Retail Price | 1121.50 AED |
Available as:
Indications
Penthrox Inhaler Inhalation is used for:
For use in the induction and maintenance of general anesthesia
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Methoxyflurane :
Mechanism of Action
Methoxyflurane induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. Methoxyflurane also activates calcium dependent ATPase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. It also appears to bind the D subunit of ATP synthase and NADH dehydogenase. Methoxyflurane also binds to the GABA receptor, the large conductance Ca2+ activated potassium channel, the glutamate receptor and the glycine receptor.
Note
Penthrox Inhaler 999mg/g Inhalation manufactured by MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED. Its generic name is Methoxyflurane. Penthrox Inhaler is availble in United Arab Emirates.
Farmaco UAE drug index information on Penthrox Inhaler Inhalation is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.